Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial
暂无分享,去创建一个
Yi-Jen Weng | Yi-Tsung Lin | Yen-Hsu Chen | S. Hsieh | Sung-Ching Pan | Charles Chen | C. Lien | Hao-Yuan Cheng | J. Estrada | Lila Estephan | Ying-Chin Lin | Paal Fure Torkehagen | Alexander Waits